Instil Bio, Inc. (TIL)
Instil Bio, Inc. operates in the Biotechnology industry of the Healthcare sector, headquartered in Dallas, TX, US. The stock last traded at $7.17, up 0.70% on the session, giving a market capitalisation of $48.6M. On trailing twelve-month figures it carries a trailing P/E of -1.60, a net margin of 0.0%. Its beta of 1.92 implies it has historically moved more than the broad market.
Instil Bio, Inc., a biopharmaceutical company, focuses on identifying and advancing therapeutic opportunities. It seeks to in-license or acquire and develop additional novel therapeutic candidates in diseases with significant unmet medical need. Instil Bio, Inc. was incorporated in 2018 and is headquartered in Dallas, Texas.
Instil Bio, Inc. is most often compared with the following Healthcare names: